Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tissue banks for molecular diagnostics].

P Schraml1

  • 1Institut für Klinische Pathologie, UniversitätsSpital Zürich, Zürich.

Therapeutische Umschau. Revue Therapeutique
|May 13, 2006
PubMed
Summary

Modern high-throughput technologies aid in identifying disease mechanisms using cell and animal models. Linking well-documented human tissues with clinico-pathological data and tissue microarrays accelerates biomarker discovery for novel diagnostics and therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma.

Oncogenesis·2017
Same author

A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization.

Oncogene·2015
Same author

Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression.

British journal of cancer·2013
Same author

Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.

Oncogene·2011
Same author

p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer.

International journal of oncology·2011
Same author

Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.

Oncogene·2010

Area of Science:

  • Molecular biology
  • Pathology
  • Biotechnology

Background:

  • High-throughput technologies in genome and proteome research identify molecular disease mechanisms.
  • Current research primarily uses cell lines and animal models, limiting direct clinical translation.
  • Pathology institutes possess valuable collections of formalin-fixed, paraffin-embedded, and frozen tissues.

Purpose of the Study:

  • To highlight the potential of well-documented human tissue collections for molecular diagnostics.
  • To emphasize the role of tissue banks and tissue microarray technology in biomarker discovery.
  • To underscore the importance of quality control and upgrading tissue banks for future clinical applications.

Main Methods:

  • Utilizing modern high-throughput technologies for genome and proteome research.
  • Leveraging existing tissue collections from pathology institutes.
  • Employing tissue microarray technology for efficient biomarker screening.
  • Linking tissue samples with comprehensive clinico-pathological data.

Main Results:

  • Tissue collections, when linked with clinical data and analyzed via tissue microarrays, enable rapid identification of potential disease biomarkers.
  • Upgraded tissue banks with quality controls offer significant potential for molecular diagnostics.
  • This approach facilitates the discovery and establishment of novel therapeutic possibilities.

Conclusions:

  • Integrating high-throughput research data with well-characterized human tissues is crucial for clinical translation.
  • Tissue banks and tissue microarray technology are powerful tools for accelerating biomarker discovery and molecular diagnostics.
  • Enhancing tissue bank infrastructure and quality control will unlock significant potential for future medical advancements.

Related Experiment Videos